Cargando…
Imaging beyond RECIST: CT and MRI in molecular therapies
Until recently, almost all systemic antineoplastic therapies in cancer patients aimed at destruction of tumor cells, i.e. they were cytotoxic. The effect of therapy was assessed by measuring the tumor size with a decrease in size suggesting response to therapy and an increase suggesting progression....
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
e-Med
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460599/ https://www.ncbi.nlm.nih.gov/pubmed/23023112 http://dx.doi.org/10.1102/1470-7330.2012.9013 |